Enovis Pre-Tax Profit Margin 2010-2024 | ENOV
Enovis pre-tax profit margin from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Enovis Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2024-03-31 | $1.82B | $-0.12B | -6.38% |
| 2023-12-31 | $1.71B | $-0.07B | -3.92% |
| 2023-09-30 | $1.66B | $-0.08B | -4.69% |
| 2023-06-30 | $1.63B | $-0.13B | -7.99% |
| 2023-03-31 | $1.59B | $0.01B | 0.31% |
| 2022-12-31 | $1.56B | $-0.00B | -0.19% |
| 2022-09-30 | $0.99B | $-0.09B | -9.24% |
| 2022-06-30 | $0.96B | $-0.03B | -3.43% |
| 2022-03-31 | $0.92B | $-0.20B | -21.15% |
| 2021-12-31 | $1.43B | $-0.12B | -8.49% |
| 2021-09-30 | $0.47B | $-0.17B | -36.79% |
| 2021-06-30 | $0.92B | $-0.12B | -12.84% |
| 2021-03-31 | $1.18B | $-0.11B | -8.88% |
| 2020-12-31 | $1.12B | $-0.12B | -10.63% |
| 2020-09-30 | $3.13B | $0.08B | 2.68% |
| 2020-06-30 | $3.17B | $0.05B | 1.58% |
| 2020-03-31 | $3.46B | $0.09B | 2.63% |
| 2019-12-31 | $3.33B | $0.05B | 1.50% |
| 2019-09-30 | $2.67B | $-0.02B | -0.56% |
| 2019-06-30 | $2.34B | $0.01B | 0.26% |
| 2019-03-31 | $2.00B | $0.04B | 1.75% |
| 2018-12-31 | $2.19B | $0.09B | 4.20% |
| 2018-09-30 | $1.48B | $-0.03B | -1.96% |
| 2018-06-30 | $1.80B | $0.01B | 0.61% |
| 2018-03-31 | $2.09B | $0.04B | 1.73% |
| 2017-12-31 | $1.94B | $0.05B | 2.53% |
| 2017-09-30 | $3.01B | $0.23B | 7.54% |
| 2017-06-30 | $2.93B | $0.22B | 7.36% |
| 2017-03-31 | $3.04B | $0.22B | 7.16% |
| 2016-12-31 | $3.19B | $0.21B | 6.47% |
| 2016-09-30 | $3.13B | $0.19B | 6.10% |
| 2016-06-30 | $3.33B | $0.17B | 5.22% |
| 2016-03-31 | $3.40B | $0.19B | 5.65% |
| 2015-12-31 | $3.43B | $0.22B | 6.35% |
| 2015-09-30 | $4.11B | $0.28B | 6.79% |
| 2015-06-30 | $4.31B | $0.35B | 8.08% |
| 2015-03-31 | $4.48B | $0.35B | 7.77% |
| 2014-12-31 | $4.62B | $0.36B | 7.74% |
| 2014-09-30 | $4.59B | $0.34B | 7.32% |
| 2014-06-30 | $4.44B | $0.32B | 7.14% |
| 2014-03-31 | $4.31B | $0.33B | 7.63% |
| 2013-12-31 | $4.21B | $0.30B | 7.20% |
| 2013-09-30 | $4.06B | $0.26B | 6.33% |
| 2013-06-30 | $4.00B | $0.20B | 5.00% |
| 2013-03-31 | $3.97B | $0.14B | 3.55% |
| 2012-12-31 | $3.91B | $0.05B | 1.25% |
| 2012-09-30 | $3.06B | $0.01B | 0.36% |
| 2012-06-30 | $2.28B | $-0.01B | -0.57% |
| 2012-03-31 | $1.42B | $-0.03B | -2.32% |
| 2011-12-31 | $0.69B | $0.02B | 2.88% |
| 2011-09-30 | $0.68B | $0.05B | 6.88% |
| 2011-06-30 | $0.65B | $0.05B | 7.75% |
| 2011-03-31 | $0.58B | $0.04B | 6.54% |
| 2010-12-31 | $0.54B | $0.03B | 4.98% |
| 2010-09-30 | $0.51B | $0.02B | 3.36% |
| 2010-06-30 | $0.50B | $0.02B | 3.58% |
| 2010-03-31 | $0.51B | $0.02B | 4.32% |
| 2009-12-31 | $0.53B | $0.03B | 6.29% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.812B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $36.275B | 19.92 |
| Inspire Medical Systems (INSP) | United States | $7.566B | 0.00 |
| Axonics (AXNX) | United States | $3.432B | 0.00 |
| 10x Genomics (TXG) | United States | $3.275B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.196B | 0.00 |
| Azenta (AZTA) | United States | $2.979B | 242.82 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.861B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.412B | 0.00 |
| Privia Health (PRVA) | United States | $2.224B | 98.63 |
| Schrodinger (SDGR) | United States | $1.712B | 0.00 |
| Omnicell (OMCL) | United States | $1.384B | 47.83 |
| Phreesia (PHR) | United States | $1.259B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.828B | 0.00 |
| Standard BioTools (LAB) | United States | $0.728B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.643B | 0.00 |
| Talkspace (TALK) | United States | $0.538B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.383B | 0.00 |
| Pulmonx (LUNG) | United States | $0.378B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.344B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.326B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.202B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.196B | 0.00 |
| American Well (AMWL) | United States | $0.165B | 0.00 |
| Outset Medical (OM) | United States | $0.162B | 0.00 |
| Augmedix (AUGX) | United States | $0.133B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.125B | 0.00 |
| TruBridge (TBRG) | United States | $0.125B | 5.33 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.108B | 0.00 |
| 111 (YI) | China | $0.096B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| Zepp Health (ZEPP) | China | $0.053B | 0.00 |
| Movano (MOVE) | United States | $0.046B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.044B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
| Cue Health (HLTH) | United States | $0.022B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.015B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Syra Health (SYRA) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |